Neuren Pharmaceuticals
NEU.AX
NZ$18.23
Share price
-0.18%
Change (1 day)
-17.31%
Change (1 year)
Categories
Neuren Pharmaceuticals (NEU.AX) - P/B ratio
P/B ratio as of July 2025 : 6.05
According to Neuren Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 10.3329.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Neuren Pharmaceuticals - P/B ratio (from 2005 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | 4.41 | -71.92% |
| 2023-12-31 | 15.7 | -36.34% |
| 2022-12-31 | 24.7 | 99.03% |
| 2021-12-31 | 12.4 | 98.34% |
| 2020-12-31 | 6.24 | -66.04% |
| 2019-12-31 | 18.4 | 215.59% |
| 2018-12-31 | 5.83 | -70.51% |
| 2017-12-31 | 19.8 | -22.64% |
| 2016-12-31 | 25.5 | 81.01% |
| 2015-12-31 | 14.1 | 38.02% |
| 2014-12-31 | 10.2 | 43.14% |
| 2013-12-31 | 7.14 | 92.4% |
| 2012-12-31 | 3.71 | 96.69% |
| 2011-12-31 | 1.89 | 32.4% |
| 2010-12-31 | 1.43 | 26.37% |
| 2009-12-31 | 1.13 | 157.58% |
| 2008-12-31 | 0.4379 | -87.77% |
| 2007-12-31 | 3.58 | 29.01% |
| 2006-12-31 | 2.77 | 71.62% |
| 2005-12-31 | 1.62 |